ES2063521T3 - Mezcla de sustancias con accion terapeutica constituida por compuestos de glutation y antociano. - Google Patents

Mezcla de sustancias con accion terapeutica constituida por compuestos de glutation y antociano.

Info

Publication number
ES2063521T3
ES2063521T3 ES91914735T ES91914735T ES2063521T3 ES 2063521 T3 ES2063521 T3 ES 2063521T3 ES 91914735 T ES91914735 T ES 91914735T ES 91914735 T ES91914735 T ES 91914735T ES 2063521 T3 ES2063521 T3 ES 2063521T3
Authority
ES
Spain
Prior art keywords
thio
substances
mixture
antocian
glutation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91914735T
Other languages
English (en)
Inventor
Gerhard Dr Med Ohlenschlager
Gernot Treusch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2063521T3 publication Critical patent/ES2063521T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

UNA MEZCLA DE SUSTANCIA PARA TRATAMIENTO TERAPEUTICO DEL CUERPO HUMANO O ANIMALES CONTIENE GLUTADION REDUCIDO Y AL MENOS UN COMPUESTO ANTOCIAN DEL GRUPO INTEGRADO POR PELARGONIDINA, PEONIDINA, CIANIDINA, MELVIDINA, PETUNIDINA Y DELFINIDINA. EL GLUTADION REDUCIDO PUEDE SER SUSTITUIDO DE FORMA COMPLETA O PARCIAL POR AL MENOS UN DERIVADO TIOL O GLUTADION DEL GRUPO INTEGRADO POR ETER METIL IONIL Y MONO
ES91914735T 1990-08-20 1991-08-20 Mezcla de sustancias con accion terapeutica constituida por compuestos de glutation y antociano. Expired - Lifetime ES2063521T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4026263 1990-08-20

Publications (1)

Publication Number Publication Date
ES2063521T3 true ES2063521T3 (es) 1995-01-01

Family

ID=6412534

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91914735T Expired - Lifetime ES2063521T3 (es) 1990-08-20 1991-08-20 Mezcla de sustancias con accion terapeutica constituida por compuestos de glutation y antociano.

Country Status (15)

Country Link
EP (1) EP0545972B1 (es)
JP (1) JPH06503554A (es)
AT (1) ATE113477T1 (es)
AU (1) AU647820B2 (es)
BG (1) BG61252B1 (es)
BR (1) BR9106784A (es)
CA (1) CA2088994C (es)
DE (1) DE59103442D1 (es)
DK (1) DK0545972T3 (es)
ES (1) ES2063521T3 (es)
HK (1) HK74597A (es)
HU (2) HU223777B1 (es)
RU (1) RU2093154C1 (es)
UA (1) UA26442C2 (es)
WO (1) WO1992003146A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100394916C (zh) * 1998-12-11 2008-06-18 密执安州大学 使用樱桃分离物提供抗氧化的、植物性或营养性益处的方法
US6448227B1 (en) 1999-02-22 2002-09-10 Gernot Treusch Therapeutically effective substance mixture
EP1074254A3 (en) * 1999-07-20 2002-09-11 MEDIS S.r.l. Medical Infusion Systems Use of plant polyphenols with vitamines for treating iron overload
FR2809003B1 (fr) * 2000-05-18 2003-01-24 Oreal Compositions anti-pollution a base d'anthocyanes
US7304210B2 (en) 2001-09-07 2007-12-04 Gain Harvest Development Ltd. Raphanus with increased anthocyanin levels
ATE398919T1 (de) 2001-09-07 2008-07-15 Gain Harvest Dev Ltd Raphanus mit erhöhtem anthocyanspiegel
JP4247833B2 (ja) * 2004-03-16 2009-04-02 株式会社ケーツーコミュニケーションズ 視機能改善剤
US8623429B2 (en) 2007-03-15 2014-01-07 Omnica Gmbh Stabilized anthocyanin compositions
US7820207B2 (en) 2007-03-15 2010-10-26 Omnica Gmbh Stabilized anthocyanin compositions
FR2972327B1 (fr) * 2011-03-11 2017-08-11 Laboratoires Le Stum Composition nutraceutique mucoadhesive comprenant une association d'antioxydants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1589294A (en) * 1976-09-08 1981-05-13 Inverni Della Beffa Spa Pharmaceutical compositions containing anthocyanidines
DE2740346A1 (de) * 1976-09-08 1978-03-09 Inverni Della Beffa Spa Arzneimittel und verfahren zu ihrer herstellung
IT1200467B (it) * 1985-05-06 1989-01-18 Boehringer Biochemia Srl Formulazione farmaceutica
DE3722647A1 (de) * 1987-07-09 1989-01-19 Gerhard Ohlenschlaeger Galenische verwendung eines tripeptids als arzneimittel

Also Published As

Publication number Publication date
AU647820B2 (en) 1994-03-31
JPH06503554A (ja) 1994-04-21
RU2093154C1 (ru) 1997-10-20
BG61252B1 (en) 1997-04-30
HU223777B1 (hu) 2005-01-28
WO1992003146A1 (de) 1992-03-05
EP0545972B1 (de) 1994-11-02
ATE113477T1 (de) 1994-11-15
BG97542A (bg) 1994-03-24
UA26442C2 (uk) 1999-08-30
DE59103442D1 (de) 1994-12-08
CA2088994A1 (en) 1992-02-21
AU8334591A (en) 1992-03-17
EP0545972A1 (de) 1993-06-16
HK74597A (en) 1997-06-13
HUT63565A (en) 1993-09-28
BR9106784A (pt) 1993-06-29
DK0545972T3 (da) 1994-11-28
CA2088994C (en) 2002-08-13
HU9300467D0 (en) 1993-05-28

Similar Documents

Publication Publication Date Title
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
IT8522574A0 (it) Composizione farmaceutica eprocedimento per trattare il corpo umano con essa.
SE8102194L (sv) Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna
ES533264A0 (es) Procedimiento para el tratamiento de tejidos corporales
ATE69376T1 (de) Haarwuchsmittel.
ES2063521T3 (es) Mezcla de sustancias con accion terapeutica constituida por compuestos de glutation y antociano.
ES545330A0 (es) Un procedimiento para preparar derivados de 1,3-difosfonato
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
DK0540676T3 (da) Peptidforbindelser med væksthormonfrigivende aktivitet
ES2085898T3 (es) Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina.
EP0215956A4 (en) AGENTS FOR TREATING SKIN DISEASES.
AU3709289A (en) Strontium salt
ES2113345T3 (es) Tratamiento de la disfuncion cardiaca con la ayuda de compuestos 15-ceto-prostaglandina.
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
AU569354B2 (en) (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
AU639322B2 (en) Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
PT661058E (pt) Utilizacao de antagonistas da bradiquinina para o tratamento de doencas virais
AR245225A1 (es) Composiciones para el tratamiento de cuero.
BR7001855U (pt) Disposicao construtiva em tronco para o tratamento de bovinos
ES512871A0 (es) "procedimiento para el tratamiento de desperdicios".
IT8722869V0 (it) Dispositivo perfezionato per l'abbronzatura artificiale integrale o parziale.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 545972

Country of ref document: ES